Related Experiment Videos
Transcriptomic Landscape of Treatment-Naïve Ulcerative Colitis
Hagar Taman1, Christopher G Fenton1, Inga V Hensel1,2
1Genomic Support Centre Tromsø [GSCT], Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.
Journal of Crohn'S & Colitis
|October 18, 2017
Summary
This study reveals new potential players in ulcerative colitis (UC) pathogenesis, highlighting a gender-dependent disease development. Findings offer insights for personalized UC treatment strategies.
Area of Science:
- Gastroenterology
- Molecular Biology
- Immunology
Background:
- Ulcerative colitis (UC) is a prevalent chronic inflammatory bowel disease (IBD) affecting the gastrointestinal tract.
- Understanding the molecular mechanisms of UC is crucial for developing effective treatments.
Purpose of the Study:
- To comprehensively define the transcriptomic landscape in treatment-naïve UC patients.
- To compare gene expression profiles with healthy controls using RNA-Seq.
Main Methods:
- RNA-Sequencing (RNA-Seq) was performed on mucosal biopsies from 14 treatment-naïve UC patients and 16 healthy controls.
- Statistical analyses, including Principal Component Analysis (PCA) and cell deconvolution, identified differentially expressed genes (DEGs).
Main Results:
- 1480 significantly differentially expressed genes (DEGs) were identified in UC patients compared to controls.
- Increased immune cell populations (monocytes, T cells, neutrophils, B cells, myeloid cells) and decreased epithelial cells were observed in UC.
- 79 DEGs were linked to IBD susceptibility, and 58 showed gender-specific expression. Potential colorectal cancer risk factors and roles for AQP9 and CLDN2 in UC were suggested.
Conclusions:
- The study identified novel potential contributors to UC pathogenesis.
- Evidence suggests a gender-dependent component in UC development.
- These findings may inform future personalized treatment approaches for UC.